GLP-1-directed NMDA receptor antagonism for obesity treatment. - Petersen J; Ludwig MQ; Juozaityte V; Ranea-Robles P; Svendsen C; Hwang E; Kristensen AW; Fadahunsi N; Lund J; Breum AW; Mathiesen CV; Sachs L; et al. (Nature, 2024)